MHRA-100932-PIP01-23-M02 (update)

Key Facts

PIPS Key Facts
Active Substance
Active Substance:
  • Defatted powder of peanuts
Invented Name
  • Palforzia
  • Palforzia
  • Palforzia
PIP Number MHRA-100932-PIP01-23-M02 (update)
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Oral powder Capsule
Therapeutic area
Therapeutic area:
  • Pneumology - Allergology
Conditions / Indications
Conditions / Indications:
  • Treatment of peanut allergy
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
Yes
Compliance Check Decision Date
Compliance opinion date
24/11/2023
Compliance Check Procedure Number
Compliance procedure number
MHRA-100932-PIP01-23-M02-C

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Defatted powder of peanuts.pdf
Published Date 19/12/2023